Glaucoma remains a leading cause of irreversible vision loss, but recent progresses in treatment have provided new avenues for patients. Novel therapies, such as targeted drug delivery systems and minimally invasive surgical procedures, are emerging traction, aiming to maintain vision by reducing intraocular pressure more effectively. Furthermore,